Immunotherapy before surgery shows promise for early lung cancer
Disease control
Completed
This study tested giving the immunotherapy drug pembrolizumab before and after surgery for people with early-stage non-small cell lung cancer. The goal was to see if this approach is safe and does not delay surgery. 35 participants were enrolled. The study looked at how the drug …
Phase: PHASE2 • Sponsor: Neal Ready MD PhD • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC